The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Endocrine and Metabolic Disturbances in Human Immunodeficiency Virus Infection and the Acquired Immune Deficiency Syndrome*
Abstract
Numerous alterations in endocrine function are observed in HIV infection. Direct destruction of endocrine organs by HIV itself or by invasive infection with opportunistic organisms resulting in loss of function is rare. When acutely ill, HIV patients can develop the metabolic derangements that accompany any severe systemic disorder. Studies of thyroid function tests emphasize that the presence of acute secondary infection must be analyzed when evaluating such patients. In addition to euthyroid sick syndrome other hormonal axes are affected by severe illness. These alterations may be cytokine mediated. As with seronegative patients, these changes can be transient and resolve with successful treatment of the intervening illness. Given the complexity of HIV disease, future reports should characterize patients by CD4 cell count, history of AIDS-indicating illnesses, and viral load. Viral burden is an independent predictor of immunosuppression and progression to AIDS. A large number of medications used in the treatment of HIV infection and related illnesses can alter endocrine function, mineral and electrolyte balance, and substrate turnover. Drug therapy must be considered in the evaluation of endocrine abnormalities in HIV-infected patients and carefully characterized in studies of these patients. The endocrine effects of medications used in the treatment of HIV infection are summarized in Table 3. Concomitant factors that affect endocrine function independent of the HIV virus can confound results in these patients. For example, opiate use affects PRL, gonadotropins, and cortisol response to ACTH stimulation. Investigations in HIV-infected patients must include careful descriptions of the study population and comparison to relevant controls. HIV-infected patients may also demonstrate more subtle alterations in endocrinological function in early, relatively asymptomatic, stages. The etiology and clinical significance of these changes, particularly their relationship to cytokines, continues to be investigated. The sequential studies of stable aldosterone levels despite decreased aldosterone response to ACTH stimulation indicate that alterations in response to provocative testing do not predict the development of hormonal insufficiency in this patient population. Similar longitudinal studies need to be done for the other hormonal axes to further delineate the endocrinological alterations in HIV infection. Finally, when the rationale for hormone replacement is debatable, double-blind, placebo-controlled studies are necessary. Transient improvement in clinical status during open-label treatment does not prove hormone insufficiency. The long-term efficacy and safety of hormonal therapy must be demonstrated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor
Sapolsky, R., Rivier, C., Yamamoto, G., Plotsky, P., & Vale, W. (1987) · Science · doi:10.1126/science.2821621 · Cited by 1,504
Alterations in thyroid function in patients with systemic illness: the euthyroid sick syndrome
WARTOFSKY, L., & BURMAN, K. D. (1982) · Endocrine Reviews · doi:10.1210/edrv-3-2-164 · Cited by 916 · cited 3×
“TSH tends to remain in the normal range although mild elevations can be seen during recovery from nonthyroidal illness (18).”
BackgroundTransient hypogonadotropic hypogonadism caused by critical illness
WOOLF, P. D., HAMILL, R. W., McDONALD, J. V., LEE, L. A., & KELLY, M. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-3-444 · Cited by 338 · cited 1×
“Patients with other severe systemic illnesses have been shown to develop hypogonadotropic hypogonadism (113).”
BackgroundCirculating interferon-α levels and hypertriglyceridemia in the acquired immunodeficiency syndrome.
Grunfeld, C., Kotler, D. P., Shigenaga, J. K., Doerrler, W., Tierney, A., Wang, J., Pierson, R. N., & Feingold, K. R. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90536-7 · Cited by 286
Tumor Necrosis Factor: A Putative Mediator of the Sick Euthyroid Syndrome in Man*
POLL, T. V. D., ROMIJN, J. A., WIERSINGA, W. M., & SAUERWEIN, H. P. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-6-1567 · Cited by 270
Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans.
Stouthard, J. M., van der Poll, T., Endert, E., Bakker, P. J., Veenhof, C. H., Sauerwein, H. P., & Romijn, J. A. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.5.7962327 · Cited by 139
Plasma Cytokines, Cytokine Antagonists, and Disease Progression in African Women Infected with HIV-1
Thea, D. M., Porat, R., Nagimbi, K., Baangi, M., St. Louis, M. E., Kaplan, G., Dinarello, C. A., & Keusch, G. T. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-8-199604150-00009 · Cited by 81 · cited 2×
“Many of the laboratories that do not find elevated cytokine levels measure free or active cytokines, while those that do find elevated cytokines measure total cytokine, which may be mostly receptor bound, hence inactive (183).”
BackgroundFindling, J. W., Buggy, B. P., Gilson, I. H., Brummitt, C. F., Bernstein, B. M., & Raff, H. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962279 · Cited by 69
The effect of antipyrine, phenobarbitol and rifampicin on thyroid hormone metabolism in man
OHNHAUS, E. E., BÜRGI, H., BURGER, A., & STUDER, H. (1981) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1981.tb02000.x · Cited by 50
Methadone induced hypoadrenalism
Dackis, C. A., Gurpegui, M., Pottash, A. L. C., & Gold, M. S. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92830-6 · Cited by 49
Cited by
Regulation of the Hypothalamic-Pituitary-Adrenal Axis by Cytokines: Actions and Mechanisms of Action
TURNBULL, A. V., & RIVIER, C. L. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.1 · Cited by 1,297
Gonzalez-Cadavid, N. F., Taylor, W. E., Yarasheski, K., Sinha-Hikim, I., Ma, K., Ezzat, S., Shen, R., Lalani, R., Asa, S., Mamita, M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14938 · Cited by 571
Dybul, M., Fauci, A. S., Bartlett, J. G., Kaplan, J. E., & Pau, A. K. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-5_part_2-200209031-00001 · Cited by 482
Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells
Taylor, W. E., Bhasin, S., Artaza, J., Byhower, F., Azam, M., Willard, D. H., Kull, F. C., & Gonzalez-Cadavid, N. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.2.e221 · Cited by 410
Bhasin, S. (2000) · JAMA · doi:10.1001/jama.283.6.763 · Cited by 369
Metadata
- Authors
- SELLMEYER, D. E., & GRUNFELD, C.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 1996-10
- Volume
- 17
- Issue
- 5
- Pages
- 518-532
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W1977757546
- Cited by
- 228
- References
- 12
- FWCI
- 17.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Endocrine and Metabolic Disturbances in Human Immunodeficiency Virus Infection and the Acquired Immune Deficiency Syndrome*. https://app.cochat.ai/papers/10.1210/edrv-17-5-518
- The paper
- SELLMEYER, D. E., & GRUNFELD, C. (1996). Endocrine and Metabolic Disturbances in Human Immunodeficiency Virus Infection and the Acquired Immune Deficiency Syndrome*. Endocrine Reviews. https://doi.org/10.1210/edrv-17-5-518
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.